Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001567619-19-013840

Director bought 1,388,889 shares at $18.00 ($25,000,002)

  • Director acquired 15,397,824 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Harrison Seth Loring · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-21 Conversion : show line 1 in the form +4,980,168 4,980,168 I
2019-06-21 Conversion : show line 2 in the form +7,617,746 12,597,914 I
2019-06-21 Conversion : show line 3 in the form +2,799,910 15,397,824 I
2019-06-21 Purchase : show line 4 in the form +1,388,889 $18.00 $25,000,002 16,786,713 I
Open-market purchases · 1,388,889 sh · avg $18.00 · $25,000,002

Table II: Derivative

3 lines
Date Transaction Shares Underlying Owned after D/I
2019-06-21 Conversion : show line 5 in the form Series A Convertible Preferred Stock −4,980,168 4,980,168 0 I
2019-06-21 Conversion : show line 6 in the form Series A-2 Convertible Preferred Stock −7,617,746 7,617,746 0 I
2019-06-21 Conversion : show line 7 in the form Series B Convertible Preferred Stock −2,799,910 2,799,910 0 I
Loading xslF345X03/doc1.xml…